Centro de Referencia e Treinamento DST/AIDS
São Paulo 04121-000
0 studies enrolling now · 5 studies all time
What they study most
COVID-19 Prevention, HIV Infections, Healthy, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
Studies at this site
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
- A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed
- A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals — Completed
- A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) — Completed